Trials / Completed
CompletedNCT04119882
Early Detection of Myocardial Ischaemia in Suspected Acute Coronary Syndromes by Apo J-Glyc
Early Detection of Myocardial Ischaemia in Suspected Acute Coronary Syndromes by Apo J-Glyc as a Novel Pathologically-based Ischaemia Biomarker
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 404 (actual)
- Sponsor
- Glycardial Diagnostics S.L. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of the study is to assess the performance characteristics of Apo J-Glyc as a novel biomarker for the early detection of myocardial ischaemia in patients with suspected acute coronary syndromes.
Detailed description
This in vitro diagnosis clinical validation will test the Performance Characteristics of Apo J-Glyc measured with a novel in vitro diagnostic (IVD) test. Blood samples from eligible consenting subjects will be collected at hospital admission, throughout different post admission times (1h, 3h, 24h and 72h or discharge). The quantification of circulating Apo J-Glyc levels will be analysed in correlation with clinical data providing information about Apo J-Glyc as an ischaemia biomarker and its diagnostic and 6-months prognostic value.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Blood collection | New biomarker test |
Timeline
- Start date
- 2019-08-20
- Primary completion
- 2021-02-10
- Completion
- 2021-09-20
- First posted
- 2019-10-09
- Last updated
- 2021-09-28
Locations
10 sites across 2 countries: Spain, United Kingdom
Source: ClinicalTrials.gov record NCT04119882. Inclusion in this directory is not an endorsement.